# Literature-review
This repository contains the list of literature included, excluded, or deemed irrelevant for the systematic literature review on the use of machine learning in disease detection and prediction of disease progression

# Included literature
[1] Agarwal D,Marques G,de la Torre-Díez I,Franco Martin MA,García Zapiraín B,Martín Rodríguez F ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118196792&doi=10.3390%2fs21217259&partnerID=40&md5=5b3466fa767cd1bef90163c4d9492cf7;http://dx.doi.org/10.3390/s21217259). Transfer learning for alzheimer’s disease through neuroimaging biomarkers: A systematic review. <br />
[2] Aksman LM,Scelsi MA,Marquand AF,Alexander DC,Ourselin S,Altmann A,For A ([2019])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067365451&doi=10.1002%2fhbm.24682&partnerID=40&md5=935551cb46aca516ffcc8f673823b202;http://dx.doi.org/10.1002/hbm.24682). Modeling longitudinal imaging biomarkers with parametric Bayesian multi-task learning. <br />
[3] Amini M,Pedram MM,Moradi A,Jamshidi M,Ouchani M ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85111490205&doi=10.1155%2f2021%2f9523039&partnerID=40&md5=98bb599923c50e8593da041f7a6c6830;http://dx.doi.org/10.1155/2021/9523039). Single and Combined Neuroimaging Techniques for Alzheimer's Disease Detection. <br />
[4] An Y,Tang K,Wang J ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117109375&doi=10.1109%2fTCBB.2021.3118418&partnerID=40&md5=69e2769c113fce186c5ce244adfe5a89;http://dx.doi.org/10.1109/TCBB.2021.3118418). Time-Aware Multi-Type Data Fusion Representation Learning Framework for Risk Prediction of Cardiovascular Diseases. <br />
[5] Bhagwat N,Viviano JD,Voineskos AN,Chakravarty MM,Alzheimer's Disease Neuroimaging I ([2018])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054563739&doi=10.1371%2fjournal.pcbi.1006376&partnerID=40&md5=9b3c845926f2119a5c67abc5f34e3474;http://dx.doi.org/10.1371/journal.pcbi.1006376). Modeling and prediction of clinical symptom trajectories in Alzheimer’s disease using longitudinal data. <br />
[6] Chan L,Nadkarni GN,Fleming F,McCullough JR,Connolly P,Mosoyan G,El Salem F,Kattan MW,Vassalotti JA,Murphy B,Donovan MJ,Coca SG,Damrauer SM ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103632574&doi=10.1007%2fs00125-021-05444-0&partnerID=40&md5=17a96f6ae49c1b94724cf16f20e20587;http://dx.doi.org/10.1007/s00125-021-05444-0). Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease. <br />
[7] Chen L,Saykin AJ,Yao B,Zhao F,Alzheimer's Disease Neuroimaging I ([2022])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85140627403&doi=10.1016%2fj.csbj.2022.10.016&partnerID=40&md5=fef00d75b293819881802ca04f4a89a6;http://dx.doi.org/10.1016/j.csbj.2022.10.016). Multi-task deep autoencoder to predict Alzheimer's disease progression using temporal DNA methylation data in peripheral blood. <br />
[8] Chen X,Gao W,Li J,You D,Yu Z,Zhang M,Shao F,Wei Y,Zhang R,Lange T,Wang Q,Chen F,Lu X,Zhao Y ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117793319&doi=10.1093%2fbib%2fbbab206&partnerID=40&md5=25d2cd918f47443a681acfc159bc92e8;http://dx.doi.org/10.1093/bib/bbab206). A predictive paradigm for COVID-19 prognosis based on the longitudinal measure of biomarkers. <br />
[9] Dadu A,Satone V,Kaur R,Hashemi SH,Leonard H,Iwaki H,Makarious MB,Billingsley KJ,Bandres-Ciga S,Sargent LJ,Noyce AJ,Daneshmand A,Blauwendraat C,Marek K,Scholz SW,Singleton AB,Nalls MA,Campbell RH,Faghri F ([2022])(http://dx.doi.org/10.1038/s41531-022-00439-zhttps://www.ncbi.nlm.nih.gov/pubmed/36526647https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758217;http://dx.doi.org/10.1038/s41531-022-00439-z;https://www.ncbi.nlm.nih.gov/pubmed/36526647;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758217). Identification and prediction of Parkinson's disease subtypes andprogression using machine learning in two cohorts. <br />
[10] Dang T,Han J,Xia T,Spathis D,Bondareva E,Siegele-Brown C,Chauhan J,Grammenos A,Hasthanasombat A,Floto RA,Cicuta P,Mascolo C ([2022])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85132454370&doi=10.2196%2f37004&partnerID=40&md5=b824bd0ecaeaf606e1103860a6adf70c;http://dx.doi.org/10.2196/37004). Exploring Longitudinal Cough, Breath, and Voice Data for COVID-19 Progression Prediction via Sequential Deep Learning: Model Development and Validation. <br />
[11] De Brouwer E,Becker T,Moreau Y,Havrdova EK,Trojano M,Eichau S,Ozakbas S,Onofrj M,Grammond P,Kuhle J,Kappos L,Sola P,Cartechini E,Lechner-Scott J,Alroughani R,Gerlach O,Kalincik T,Granella F,Grand'Maison F,Bergamaschi R,José Sá M,Van Wijmeersch B,Soysal A,Sanchez-Menoyo JL,Solaro C,Boz C,Iuliano G,Buzzard K,Aguera-Morales E,Terzi M,Trivio TC,Spitaleri D,Van Pesch V,Shaygannejad V,Moore F,Oreja-Guevara C,Maimone D,Gouider R,Csepany T,Ramo-Tello C,Peeters L ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85107912293&doi=10.1016%2fj.cmpb.2021.106180&partnerID=40&md5=b3cca281cf5b7f06be000ef905ec1976;http://dx.doi.org/10.1016/j.cmpb.2021.106180). Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression. <br />
[12] Dinov ID,Heavner B,Tang M,Glusman G,Chard K,Darcy M,Madduri R,Pa J,Spino C,Kesselman C,Foster I,Deutsch EW,Price ND,Van Horn JD,Ames J,Clark K,Hood L,Hampstead BM,Dauer W,Toga AW ([2016])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-84983464569&doi=10.1371%2fjournal.pone.0157077&partnerID=40&md5=accecdee9041c5387c76f70989318b33;http://dx.doi.org/10.1371/journal.pone.0157077). Predictive big data analytics: A study of Parkinson's disease using large, complex, heterogeneous, incongruent, multi-source and incomplete observations. <br />
[13] Donovan MJ,Khan FM,Fernandez G,Mesa-Tejada R,Sapir M,Zubek VB,Powell D,Fogarasi S,Vengrenyuk Y,Teverovskiy M,Segal MR,Karnes RJ,Gaffey TA,Busch C,Haggman M,Hlavcak P,Freedland SJ,Vollmer RT,Albertsen P,Costa J,Cordon-Cardo C ([2009])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-67349084186&doi=10.1016%2fj.juro.2009.02.135&partnerID=40&md5=6c9cca1fc5fcbafd118069927d2f84f9;http://dx.doi.org/10.1016/j.juro.2009.02.135). Personalized Prediction of Tumor Response and Cancer Progression on Prostate Needle Biopsy. <br />
[14] El-Sappagh S,Saleh H,Ali F,Amer E,Abuhmed T ([2022])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85129575868&doi=10.1007%2fs00521-022-07263-9&partnerID=40&md5=8e08ad078937befb78ecc20fec58058a;http://dx.doi.org/10.1007/s00521-022-07263-9). Two-stage deep learning model for Alzheimer’s disease detection and prediction of the mild cognitive impairment time. <br />
[15] Eng SW,Aeschlimann FA,van Veenendaal M,Berard RA,Rosenberg AM,Morris Q,Yeung RS ([2019])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063387183&doi=10.1371%2fjournal.pmed.1002750&partnerID=40&md5=8c3abe5f9d59dc64cbc8e6ba5d239d2e;http://dx.doi.org/10.1371/journal.pmed.1002750). Patterns of joint involvement in juvenile idiopathic arthritis and prediction of disease course: A prospective study with multilayer non-negative matrix factorization. <br />
[16] Fernandes F,Barbalho I,Barros D,Valentim R,Teixeira C,Henriques J,Gil P,Dourado Júnior M ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85108088734&doi=10.1186%2fs12938-021-00896-2&partnerID=40&md5=3c3276609bc5c1bebe20a4355054d138;http://dx.doi.org/10.1186/s12938-021-00896-2). Biomedical signals and machine learning in amyotrophic lateral sclerosis: a systematic review. <br />
[17] Franzmeier N,Koutsouleris N,Benzinger T,Goate A,Karch CM,Fagan AM,McDade E,Duering M,Dichgans M,Levin J,Gordon BA,Lim YY,Masters CL,Rossor M,Fox NC,O'Connor A,Chhatwal J,Salloway S,Danek A,Hassenstab J,Schofield PR,Morris JC,Bateman RJ,Ewers M,the Alzheimer's disease neuroimaging I,the Dominantly Inherited Alzheimer N ([2020])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079448777&doi=10.1002%2falz.12032&partnerID=40&md5=3040e61c8a0901032c8c108f5ef22734;http://dx.doi.org/10.1002/alz.12032). Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning. <br />
[18] Giorgio J,Landau SM,Jagust WJ,Tino P,Kourtzi Z ([2020])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079876177&doi=10.1016%2fj.nicl.2020.102199&partnerID=40&md5=a4b8d57a963bc91427695e9dd3a43b03;http://dx.doi.org/10.1016/j.nicl.2020.102199). Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease. <br />
[19] Goenka N,Tiwari S ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85106049108&doi=10.1007%2fs10462-021-10016-0&partnerID=40&md5=f3a558d7ccf119b2cbb5f0126e3d61ab;http://dx.doi.org/10.1007/s10462-021-10016-0). Deep learning for Alzheimer prediction using brain biomarkers. <br />
[20] He K,Huang S,Qian XN ([2019])(http://dx.doi.org/10.1016/j.jbi.2019.103231). Early detection and risk assessment for chronic disease with irregular longitudinal data analysis. <br />
[21] Ho NH,Yang HJ,Kim J,Dao DP,Park HR,Pant S ([2022])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85127207314&doi=10.1016%2fj.neunet.2022.03.016&partnerID=40&md5=d232048bf57a6dc9ea0bd24da790c5dc;http://dx.doi.org/10.1016/j.neunet.2022.03.016). Predicting progression of Alzheimer's disease using forward-to-backward bi-directional network with integrative imputation. <br />
[22] Hossain MZ,Daskalaki E,Brustle A,Desborough J,Lueck CJ,Suominen H ([2022])(https://bmcmedinformdecismak.biomedcentral.com/counter/pdf/10.1186/s12911-022-01985-5.pdf;http://dx.doi.org/10.1186/s12911-022-01985-5). The role of machine learning in developing non-magnetic resonance imaging based biomarkers for multiple sclerosis: a systematic review. <br />
[23] Hu Z,Wang Z,Jin Y,Hou W ([2023])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85143653318&doi=10.1016%2fj.cmpb.2022.107291&partnerID=40&md5=539ba866ed9591c74b04aa9ae33808c1;http://dx.doi.org/10.1016/j.cmpb.2022.107291). VGG-TSwinformer: Transformer-based deep learning model for early Alzheimer's disease prediction. <br />
[24] Jiang P,Wang X,Li Q,Jin L,Li S ([2019])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058134503&doi=10.1109%2fJBHI.2018.2885331&partnerID=40&md5=2b0b18a0e62916d226164c2273cd97a1;http://dx.doi.org/10.1109/JBHI.2018.2885331). Correlation-Aware Sparse and Low-Rank Constrained Multi-Task Learning for Longitudinal Analysis of Alzheimer's Disease. <br />
[25] Jung W,Jun E,Suk HI,Alzheimer's Disease Neuroimaging I ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85106926249&doi=10.1016%2fj.neuroimage.2021.118143&partnerID=40&md5=32cda0a30cd854fa40991d1d507323e1;http://dx.doi.org/10.1016/j.neuroimage.2021.118143). Deep recurrent model for individualized prediction of Alzheimer's disease progression. <br />
[26] Kaur P,Singh A,Chana I ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100042332&doi=10.1007%2fs11831-021-09547-0&partnerID=40&md5=bb8528c191511330b81e8cd48f264be9;http://dx.doi.org/10.1007/s11831-021-09547-0). Computational Techniques and Tools for Omics Data Analysis: State-of-the-Art, Challenges, and Future Directions. <br />
[27] Kavakiotis I,Tsave O,Salifoglou A,Maglaveras N,Vlahavas I,Chouvarda I ([2017])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85010004915&doi=10.1016%2fj.csbj.2016.12.005&partnerID=40&md5=9c6ebf06d045ffd1d34793873d9e2b60;http://dx.doi.org/10.1016/j.csbj.2016.12.005). Machine Learning and Data Mining Methods in Diabetes Research. <br />
[28] Kendrick J,Francis R,Hassan GM,Rowshanfarzad P,Jeraj R,Kasisi C,Rusanov B,Ebert M ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85119109410&doi=10.3389%2ffonc.2021.771787&partnerID=40&md5=945e516e05218cefb33af71b38fa18bd;http://dx.doi.org/10.3389/fonc.2021.771787). Radiomics for Identification and Prediction in Metastatic Prostate Cancer: A Review of Studies. <br />
[29] Larie D,An G,Cockrell RC ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118306539&doi=10.3389%2ffphys.2021.716434&partnerID=40&md5=485c7a2b0e641aebb27b14a2eca1fe42;http://dx.doi.org/10.3389/fphys.2021.716434). The Use of Artificial Neural Networks to Forecast the Behavior of Agent-Based Models of Pathophysiology: An Example Utilizing an Agent-Based Model of Sepsis. <br />
[30] Lee G,Nho K,Kang B,Sohn KA,Kim D,Weiner MW,Aisen P,Petersen R,Jack C. R J,Jagust W,Trojanowki JQ,Toga AW,Beckett L,Green RC,Saykin AJ,Morris J,Shaw LM,Khachaturian Z,Sorensen G,Carrillo M,Kuller L,Raichle M,Paul S,Davies P,Fillit H,Hefti F,Holtzman D,Mesulam MM,Potter W,Snyder P,Montine T,Thomas RG,Donohue M,Walter S,Sather T,Jiminez G,Balasubramanian AB,Mason J,Sim I,Harvey D,Bernstein M,Fox N,Thompson P,Schuff N,DeCarli C,Borowski B,Gunter J,Senjem M,Vemuri P,Jones D,Kantarci K,Ward C,Koeppe RA,Foster N,Reiman EM,Chen K,Mathis C,Landau S,Cairns NJ,Householder E,Taylor-Reinwald L,Lee V,Korecka M,Figurski M,Crawford K,Neu S,Foroud TM,Potkin S,Shen L,Faber K,Kim S,Tha L,Frank R,Hsiao J,Kaye J,Quinn J,Silbert L,Lind B,Carter R,Dolen S,Ances B,Carroll M,Creech ML,Franklin E,Mintun MA,Schneider S,Oliver A,Schneider LS,Pawluczyk S,Beccera M,Teodoro L,Spann BM,Brewer J,Vanderswag H,Fleisher A,Marson D,Griffith R,Clark D,Geldmacher D,Brockington J,Others ([2019])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061494936&doi=10.1038%2fs41598-018-37769-z&partnerID=40&md5=7689a4625192649345c089eaec1fae7f;http://dx.doi.org/10.1038/s41598-018-37769-z). Predicting Alzheimer’s disease progression using multi-modal deep learning approach. <br />
[31] Li Z,Jiang X,Wang Y,Kim Y ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122615178&doi=10.1042%2fETLS20210249&partnerID=40&md5=1972694c9d2daa4f9a50741fc78c04bd;http://dx.doi.org/10.1042/ETLS20210249). Applied machine learning in Alzheimer's disease research: Omics, imaging, and clinical data. <br />
[32] Liu X,Wang J,Ren F,Kong J ([2020])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079763650&doi=10.1155%2f2020%2f4036560&partnerID=40&md5=08c4a7d1cc23a6e416a222713150e8ef;http://dx.doi.org/10.1155/2020/4036560). Group Guided Fused Laplacian Sparse Group Lasso for Modeling Alzheimer's Disease Progression. <br />
[33] Ma LY,Tian Y,Pan CR,Chen ZL,Ling Y,Ren K,Li JS,Feng T ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100614818&doi=10.3389%2ffnagi.2020.627199&partnerID=40&md5=f21abe689e0fe94197a31384b128b5e1;http://dx.doi.org/10.3389/fnagi.2020.627199). Motor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers. <br />
[34] Marcos-Zambrano LJ,Karaduzovic-Hadziabdic K,Loncar Turukalo T,Przymus P,Trajkovik V,Aasmets O,Berland M,Gruca A,Hasic J,Hron K,Klammsteiner T,Kolev M,Lahti L,Lopes MB,Moreno V,Naskinova I,Org E,Paciência I,Papoutsoglou G,Shigdel R,Stres B,Vilne B,Yousef M,Zdravevski E,Tsamardinos I,Carrillo de Santa Pau E,Claesson MJ,Moreno-Indias I,Truu J,Ml4Microbiome ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102368878&doi=10.3389%2ffmicb.2021.634511&partnerID=40&md5=677581bf4584c57cfdcb1802b821fd38;http://dx.doi.org/10.3389/fmicb.2021.634511). Applications of Machine Learning in Human Microbiome Studies: A Review on Feature Selection, Biomarker Identification, Disease Prediction and Treatment. <br />
[35] Marti-Juan G,Sanroma-Guell G,Piella G ([2020])(http://dx.doi.org/10.1016/j.cmpb.2020.105348). A survey on machine and statistical learning for longitudinal analysis of neuroimaging data in Alzheimer's disease. <br />
[36] Mistry S,Riches NO,Gouripeddi R,Facelli JC ([2023])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85143160402&doi=10.1016%2fj.artmed.2022.102461&partnerID=40&md5=14133a4ba6959181f311eb6cce90a80b;http://dx.doi.org/10.1016/j.artmed.2022.102461). Environmental exposures in machine learning and data mining approaches to diabetes etiology: A scoping review. <br />
[37] Morino K,Hirata Y,Tomioka R,Kashima H,Yamanishi K,Hayashi N,Egawa S,Aihara K ([2015])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930226442&doi=10.1038%2fsrep08953&partnerID=40&md5=16def2aec33fa6ae082f63c03568da7a;http://dx.doi.org/10.1038/srep08953). Predicting disease progression from short biomarker series using expert advice algorithm. <br />
[38] Nazha A,Komrokji R,Meggendorfer M,Jia X,Radakovich N,Shreve J,Beau Hilton C,Nagata Y,Hamilton BK,Mukherjee S,Al Ali N,Walter W,Hutter S,Padron E,Sallman D,Kuzmanovic T,Kerr C,Adema V,Steensma DP,Dezern A,Roboz G,Garcia-Manero G,Erba H,Haferlach C,Maciejewski JP,Haferlach T,Sekeres MA ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85121963237&doi=10.1200%2fJCO.20.02810&partnerID=40&md5=41b47cd9abcb5b48d644df5a2e9110a8;http://dx.doi.org/10.1200/JCO.20.02810). Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes. <br />
[39] Papaiz F,Dourado M. E. T J,Valentim RA,de Morais AH,Arrais JP ([2022])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130128050&doi=10.3389%2ffcomp.2022.869140&partnerID=40&md5=cc085ccb47e6b5326f17695be631b9a9;http://dx.doi.org/10.3389/fcomp.2022.869140). Machine Learning Solutions Applied to Amyotrophic Lateral Sclerosis Prognosis: A Review. <br />
[40] Sadiq MU,Kwak K,Dayan E,for the Alzheimer's Disease Neuroimaging I ([2022])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85123601462&doi=10.1186%2fs13195-021-00941-1&partnerID=40&md5=148c38974a78fa11f0b104d59ea5027b;http://dx.doi.org/10.1186/s13195-021-00941-1). Model-based stratification of progression along the Alzheimer disease continuum highlights the centrality of biomarker synergies. <br />
[41] Schmidt-Erfurth U,Waldstein SM,Klimscha S,Sadeghipour A,Hu X,Gerendas BS,Osborne A,Bogunović H ([2018])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049601936&doi=10.1167%2fiovs.18-24106&partnerID=40&md5=5aed83b6c68a54f097ae848d3c5a40e8;http://dx.doi.org/10.1167/iovs.18-24106). Prediction of individual disease conversion in early AMD using artificial intelligence. <br />
[42] Seccia R,Romano S,Salvetti M,Crisanti A,Palagi L,Grassi F ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101021093&doi=10.3390%2flife11020122&partnerID=40&md5=0b9ef0112ed0a238a0e8068385fbf862;http://dx.doi.org/10.3390/life11020122). Machine learning use for prognostic purposes in multiple sclerosis. <br />
[43] Sehulam P,Saria S ([2016])(https://www.jmlr.org/papers/v17/15-436.html). Integrative Analysis using Coupled Latent Variable Models for Individualizing Prognoses. <br />
[44] Shafiee N,Dadar M,Ducharme S,Collins DL ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85120483076&doi=10.3233%2fJAD-210664&partnerID=40&md5=94bbb85dd8cd7b250c3a0e53d84cd51a;http://dx.doi.org/10.3233/JAD-210664). Automatic Prediction of Cognitive and Functional Decline Can Significantly Decrease the Number of Subjects Required for Clinical Trials in Early Alzheimer's Disease. <br />
[45] Sharma R,Anand H,Badr Y,Qiu RG ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124429433&doi=10.1002%2ftrc2.12229&partnerID=40&md5=b0fd70674988038959b48afff855c3d9;http://dx.doi.org/10.1002/trc2.12229). Time-to-event prediction using survival analysis methods for Alzheimer's disease progression. <br />
[46] Shiino A,Shirakashi Y,Ishida M,Tanigaki K,Japanese Alzheimer's Disease Neuroimaging I ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85133511960&doi=10.1002%2fdad2.12246&partnerID=40&md5=6d82439a4af33cb9081db8b48b3e9f4f;http://dx.doi.org/10.1002/dad2.12246). Machine learning of brain structural biomarkers for Alzheimer's disease (AD) diagnosis, prediction of disease progression, and amyloid beta deposition in the Japanese population. <br />
[47] Shu ZY,Cui SJ,Wu X,Xu Y,Huang P,Pang PP,Zhang M ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85092064628&doi=10.1002%2fmrm.28522&partnerID=40&md5=86d9d0f20b1465b33ae593185baa55a8;http://dx.doi.org/10.1002/mrm.28522). Predicting the progression of Parkinson's disease using conventional MRI and machine learning: An application of radiomic biomarkers in whole-brain white matter. <br />
[48] Silva JF,Matos S ([2022])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85138488865&doi=10.1016%2fj.jbi.2022.104195&partnerID=40&md5=58a93e378a128cdf157b08ecf33e7101;http://dx.doi.org/10.1016/j.jbi.2022.104195). Modelling patient trajectories using multimodal information. <br />
[49] Sindelar M,Stancliffe E,Schwaiger-Haber M,Anbukumar DS,Adkins-Travis K,Goss CW,O'Halloran JA,Mudd PA,Liu WC,Albrecht RA,García-Sastre A,Shriver LP,Patti GJ ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112056592&doi=10.1016%2fj.xcrm.2021.100369&partnerID=40&md5=fa5d30e997e4462a002b94478a66999a;http://dx.doi.org/10.1016/j.xcrm.2021.100369). Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity. <br />
[50] Singh NP,Bapi RS,Vinod PK ([2018])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049345462&doi=10.1016%2fj.compbiomed.2018.06.030&partnerID=40&md5=d815eea9deea724d04c26c5104c0197b;http://dx.doi.org/10.1016/j.compbiomed.2018.06.030). Machine learning models to predict the progression from early to late stages of papillary renal cell carcinoma. <br />
[51] Su C,Xu Z,Pathak J,Wang F ([2020])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086372857&doi=10.1038%2fs41398-020-0780-3&partnerID=40&md5=d6c7bba0c3d7fc265e9935426dfd60f9;http://dx.doi.org/10.1038/s41398-020-0780-3). Deep learning in mental health outcome research: a scoping review. <br />
[52] Su W,Wang X,Szczesniak RD ([2020])(http://dx.doi.org/10.1111/biom.13291https://www.ncbi.nlm.nih.gov/pubmed/32413169https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803535;http://dx.doi.org/10.1111/biom.13291;https://www.ncbi.nlm.nih.gov/pubmed/32413169;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803535). Flexible link functions in a joint hierarchical Gaussian process model. <br />
[53] Sun C,Hong S,Song M,Li H,Wang Z ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101151852&doi=10.1186%2fs12911-020-01359-9&partnerID=40&md5=6a29960cf4d7964ea885065e18d451f9;http://dx.doi.org/10.1186/s12911-020-01359-9). Predicting COVID-19 disease progression and patient outcomes based on temporal deep learning. <br />
[54] Sun C,Li H,Mills RE,Guan Y ([2019])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077324877&doi=10.1093%2fgigascience%2fgiz153&partnerID=40&md5=35c7c71917fd4bf8d861870d450d22b8;http://dx.doi.org/10.1093/gigascience/giz153). Prognostic model for multiple myeloma progression integrating gene expression and clinical features. <br />
[55] Taghavi M,Staal F,Gomez Munoz F,Imani F,Meek DB,Simões R,Klompenhouwer LG,van der Heide UA,Beets-Tan RG,Maas M ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099939333&doi=10.1007%2fs00270-020-02735-8&partnerID=40&md5=845d62df119d489152a9d02a00b1661a;http://dx.doi.org/10.1007/s00270-020-02735-8). CT-Based Radiomics Analysis Before Thermal Ablation to Predict Local Tumor Progression for Colorectal Liver Metastases. <br />
[56] Uphaus T,Steffen F,Muthuraman M,Ripfel N,Fleischer V,Groppa S,Ruck T,Meuth SG,Pul R,Kleinschnitz C,Ellwardt E,Loos J,Engel S,Zipp F,Bittner S ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85115651225&doi=10.1016%2fj.ebiom.2021.103590&partnerID=40&md5=242acf455fb661bf0da83c03d6c6ab70;http://dx.doi.org/10.1016/j.ebiom.2021.103590). NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study: Serum NfL predicts relapse-free progression. <br />
[57] Velazquez M,Lee Y,for the Alzheimer's Disease Neuroimaging I ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104954959&doi=10.1371%2fjournal.pone.0244773&partnerID=40&md5=7fb01a95008cbdf13b06fa3bf7708532;http://dx.doi.org/10.1371/journal.pone.0244773). Random forest model for feature-based Alzheimer’s disease conversion prediction from early mild cognitive impairment subjects. <br />
[58] Wang M,Zhang D,Shen D,Liu M ([2019])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061314085&doi=10.1016%2fj.media.2019.01.007&partnerID=40&md5=fc1447671c450e076a8b7f9f788ce9b1;http://dx.doi.org/10.1016/j.media.2019.01.007). Multi-task exclusive relationship learning for alzheimer's disease progression prediction with longitudinal data. <br />
[59] Weaver JK,Milford K,Rickard M,Logan J,Erdman L,Viteri B,D'Souza N,Cucchiara A,Skreta M,Keefe D,Shah S,Selman A,Fischer K,Weiss DA,Long CJ,Lorenzo A,Fan Y,Tasian GE ([2022])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85134665996&doi=10.1007%2fs00467-022-05677-0&partnerID=40&md5=a88d477d2f00f16c0b0ced38891ea08e;http://dx.doi.org/10.1007/s00467-022-05677-0). Deep learning imaging features derived from kidney ultrasounds predict chronic kidney disease progression in children with posterior urethral valves. <br />
[60] Westerlund AM,Hawe JS,Heinig M,Schunkert H ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85115660689&doi=10.3390%2fijms221910291&partnerID=40&md5=e8650824aed158ea804f0a5d2bc45a31;http://dx.doi.org/10.3390/ijms221910291). Risk prediction of cardiovascular events by exploration of molecular data with explainable artificial intelligence. <br />
[61] Yılmaz Acar Z,Başçiftçi F,Ekmekci AH ([2022])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85133525003&doi=10.1016%2fj.bspc.2022.103940&partnerID=40&md5=ee33f661cb5371da3e00f4e58d494ebe;http://dx.doi.org/10.1016/j.bspc.2022.103940). Future activity prediction of multiple sclerosis with 3D MRI using 3D discrete wavelet transform. <br />
[62] Zhang J,Ning J,Huang X,Li R ([2021])(http://dx.doi.org/10.1002/sim.9111https://www.ncbi.nlm.nih.gov/pubmed/34159633https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751424;http://dx.doi.org/10.1002/sim.9111;https://www.ncbi.nlm.nih.gov/pubmed/34159633;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751424). On the time-varying predictive performance of longitudinal biomarkers:Measure and estimation. <br />
[63] Zheng Y,Hu X ([2020])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085334661&doi=10.1007%2fs10844-020-00606-9&partnerID=40&md5=5f1ad9b356891194fc23a063d11a3526;http://dx.doi.org/10.1007/s10844-020-00606-9). Healthcare predictive analytics for disease progression: a longitudinal data fusion approach. <br />
[64] Zhou Y,Song Z,Han X,Li H,Tang X ([2021])(https://www.scopus.com/inward/record.uri?eid=2-s2.0-85119063813&doi=10.1021%2facschemneuro.1c00472&partnerID=40&md5=bc19e79e2ff45ea7a3d2161f873b3048;http://dx.doi.org/10.1021/acschemneuro.1c00472). Prediction of Alzheimer's Disease Progression Based on Magnetic Resonance Imaging. <br />

# Excluded literature


# Irrelevant literature
